ArticleGastro hep advances2024

Lanifibranor Reduces Inflammation and Improves Dyslipidemia in Lysosomal Acid Lipase-Deficient Mice.

Ivan Bradić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.